Pasireotide, an agent developed initially for treating such pituitary disorders as Cushing disease, is expensive, with monthly costs that can run into thousands of dollars. In this report, although ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results